Advertisement
News
Subscribe to MDT Magazine News

Scorpion has welcome sting for heart bypass patients

October 22, 2010 7:34 am | by EurekAlert | Comments

(University of Leeds) A toxin found in the venom of the Central American bark scorpion (Centruroides margaritatus) could hold the key to reducing heart bypass failures, according to research from the University of Leeds.

TOPICS:

CEO Termeer: Genzyme worth even more – $89 per share

October 22, 2010 7:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Corp. CEO Henri Termeer said the company’s profits will more than double next year, and that proves the company has been significantly undervalued by the acquisition offer of $69 per share from French drug maker Sanofi-aventis.

INVOcell Study Results to be Reported at the Annual Meeting of The American Society of Reproductive Medicine

October 22, 2010 7:32 am | by Bio-Medicine.Org | Comments

DENVER and BEVERLY, Mass., Oct. 22 /- INVO Bioscience, Inc. (OTC Bulltin Board: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, today announced that Dr. Elkin Lucena of the Columbian Fertility and Sterility Center (CECOFLES LTDA) will...

TOPICS:
Advertisement

Social interaction can identify mental pathology

October 22, 2010 7:32 am | by Baylor College of Medicine | Comments

If your doctor thinks your blood pressure is too high, she can measure it with an instrument. If she thinks you are anemic, she can order a lab test. Psychiatrists seeking to identify mental disorders must depend on less precise measures – observations of behaviors and various...

TOPICS:

Children's Hospital granted $3M to study rare blood disease

October 22, 2010 7:32 am | by Mass High Tech: The Journal of New England Technology | Comments

Children’s Hospital Boston has received a $3.9 million grant from the National Institutes of Health to work on a treatment on a fatal genetic blood disease called Fanconi anemia.

TOPICS:

Thoratec Schedules Third Quarter Conference Call, Webcast

October 22, 2010 7:32 am | by Bio-Medicine.Org | Comments

PLEASANTON, Calif., Oct. 22 /- Thoratec Corporation (Nasdaq: THOR ), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the third quarter and first nine months...

TOPICS:

GE to buy diagnostics company Clarient

October 22, 2010 6:45 am | by The Associated Press | Comments

General Electric Co. said Friday its healthcare unit will buy diagnostics company Clarient Inc. in a deal aimed at speeding its expansion into cancer diagnostic and therapy selection tools.GE Healthcare officials say the deal will help them build a $1 billion-plus business developing integrated...

St. Jude Medical to buy back up to $300M in shares

October 22, 2010 6:45 am | by The Associated Press | Comments

St. Jude Medical Inc., a medical device maker, said Friday it will repurchase up to $300 million in stock.The program is in addition to the $600 million share repurchase program already announced.Shares acquired during the program will be used for general corporate purposes. The company had...

Advertisement

Teaching kids to work through trauma

October 22, 2010 6:34 am | by EurekAlert | Comments

(American Friends of Tel Aviv University) A child who grows up in the midst of political conflict, such as war or terrorism, can exhibit severe emotional scars. But certain qualities, which psychologists call "resilience factors," can help overcome this adversity. Prof. Michelle...

TOPICS:

Boston Scientific Announces CE Mark Approval for Expanded Indication of WallFlex® Biliary RX Stent

October 22, 2010 4:32 am | by Boston Scientific | Comments

Company's fully covered metal stent now approved for use in treating benign biliary strictures

TOPICS:

Emerson enters residential & small business renewable energy market with new 5kW grid tie solar inverter

October 22, 2010 1:34 am | by I-Micronews | Comments

Emerson Network Power launched the SPV-5.0 grid tie solar inverter, marking the company?s entry into the residential and small business renewable energy market.

Align moves to profit in 3Q

October 21, 2010 5:45 pm | by The Associated Press | Comments

Align Technology Inc. said Thursday it posted a profit in the third quarter, reversing a prior-year loss when the dental products company absorbed hefty costs related to a patent lawsuit settlement.The company, which makes the teeth-straightening system Invisalign, also revised its...

Cantel raises dividend

October 21, 2010 3:45 pm | by The Associated Press | Comments

Cantel Medical Corp., which makes products used to prevent infections, said on Thursday that it would raise its semiannual dividend to 6 cents per share.The dividend will be paid Jan. 28 to shareholders of record Jan. 14.The company previously paid a semiannual dividend of 5 cents per share....

Orthovita says 3Q revenue grew 5 percent to $23.3M

October 21, 2010 12:45 pm | by The Associated Press | Comments

Orthovita Inc., an orthopedic and surgical products maker, said Thursday its revenue rose 5 percent in the third quarter over the same period last year.The company said product sales grew to $23.3 million from $22.3 million. It said revenue from its Cortoss bone augmentation material and...

New Label Changes for Commonly Prescribed HIV Drug Invirase

October 21, 2010 12:32 pm | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., Oct. 21 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir), describing potentially life-threatening side effects on the heart when...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading